Regulus Therapeutics
RGLS
#8838
Rank
S$0.15 B
Marketcap
$2.27
Share price
-6.39%
Change (1 day)
-35.55%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -S$61.58 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$39.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -S$62.17 Million56.97%
2023 -S$39.61 Million6.51%
2022 -S$37.19 Million2.53%
2021 -S$36.27 Million93.59%
2020 -S$18.74 Million-15.41%
2019 -S$22.15 Million-64.46%
2018 -S$62.31 Million-33.26%
2017 -S$93.37 Million-13.98%
2016 -S$0.11 Billion44.77%
2015 -S$74.98 Million-1.63%
2014 -S$76.22 Million203.6%
2013 -S$25.11 Million8.65%
2012 -S$23.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$5.91 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$10.68 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.56 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.03 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$0.32 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.28 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA